GE HealthCare Technologies Commences Underwritten Debt Offering

Details

commenced and priced an underwritten offering of $600,000,000 of 4.150% Notes due December 15, 2028 and $650,000,000 of 4.950% Notes due December 15, 2035. The Notes are expected to be issued on or around December 15, 2025, subject to customary closing conditions. An Underwriting Agreement was entered into with Goldman Sachs & Co. LLC and BNP Paribas Securities Corp., as representatives of the several underwriters named therein.

Items reported

About Ge Healthcare Technologies Inc.

Ge Healthcare Technologies Inc. is a prominent player in the healthcare industry, focused on providing transformative medical technology and diagnostic solutions. Specializing in imaging, monitoring, and diagnostic equipment, the company plays a crucial role in enhancing clinical outcomes, improving patient care, and driving medical technology innovations. Ge Healthcare Technologies Inc. is recognized for its advancements in medical imaging systems, including MRI, CT, and ultrasound technologies, which aid in early disease detection and treatment planning. In addition to its hardware innovations, the company is actively involved in digital healthcare solutions, employing data analytics and AI to support precise diagnoses and personalized medicine. The impact of Ge Healthcare Technologies extends across various healthcare sectors, including hospitals, clinics, and research institutions, underscoring its importance in advancing clinical capabilities and operational efficiencies within the healthcare system. Ge Healthcare Technologies Inc. maintains a strategic presence in global markets, bolstering healthcare infrastructure and supporting public health initiatives. By continuously striving to innovate and improve healthcare delivery, it remains a significant entity within the broader medical technology and life sciences industry, contributing to the future of healthcare.